However, blockade of the VEGF pathway is too narrow an approach to prevent outgrowth of residual carcinoma when more than a critical tumour burden is present, as the drug effect is overwhelmed by proangiogenic signals and the tumour may use other compensatory angiogenic pathways. Here, VEGFA is linked to neoplasm.